Abstract:As global ageing deepens and galanthamine is the preferred clinical drug for the treatment of mild to moderate Alzheimer's disease, it will be valuable to examine the behaviour and mechanism of galanthamine's thermal decomposition for its quality control, formulation process, evaluation of thermal stability, and expiry date in production. In order to study the pyrolysis of galanthamine hydrobromide with nitrogen as the carrier gas, a thermogravimetric-differential thermogravimetric technique (TG-DTG) was applied at a temperature rise rate of 10 K min −1 and a volume flow rate of 35 mL min −1 . The apparent activation energy E a and the prefactor A ( E a = 224.45 kJ mol −1 and lnA = 47.40) of the thermal decomposition reaction of galanthamine hydrobromide were calculated according to the multiple heating rate method (Kissinger and Ozawa) and the single heating rate method (Coats-Redfern and Achar), and the most probable mechanism function was derived, and then the storage period was inferred from E a and E . A three-dimensional diffusion mechanism was suggested to control the thermal decomposition of galanthamine hydrobromide in accordance with the Jander equation, random nucleation and subsequent growth control, corresponding to the Mample one-way rule and the Avrami-Erofeev equation. As a result, the thermal decomposition temperature of galanthamine hydrobromide gradually increased with the rate of temperature rise. From Gaussian simulations and thermogravimetric data, galanthamine hydrobromide decomposed at the first stage (518.25–560.75 K) to release H 2 O, at the second stage (563.25–650.75 K) to generate CO, CO 2 , NH 3 and other gases, and finally at the third stage (653.25–843.25 K) to release CO 2 . After 843.25 K, the residual molecular skeleton is cleaved to release CO 2 and H 2 O. According to the E a and A presenting in the first stage of thermal decomposition, it is assumed that the storage life of galanthamine hydrobromide at room temperature 298.15 K is 4–5 years.

Semi-synthesis of galanthamine

Research on Total Synthesis of Racemic Galanthamine

Formal Synthesis of (±)-Galanthamine and (±)-Lycoramine Using Rh(I)-catalyzed [(3 + 2) + 1] Cycloaddition of 1-Ene-vinylcyclopropane and CO.

Catalytic Asymmetric Total Synthesis of (−)‐galanthamine and (−)‐Lycoramine

The synthesis of N -ethyl- n -butylamine by amines disproportionation

Rh-catalysed [5 + 1] Cycloaddition of Allenylcyclopropanes and CO: Reaction Development and Application to the Formal Synthesis of (−)-Galanthamine

Diastereospecific epoxidation and highly regioselective ring-opening of (+)-valienamine: Practical synthesis of (+)-valiolamine

Study on the Synthesis of L-4-Nitrophenylalanine

Synthesis of Cyclopentylamine

Analysis on the thermal decomposition kinetics and storage period of biomass-based lycorine galanthamine

Synthesis, spectral characterization and biological evaluation of phosphorylated derivatives of galanthamine

Rhodium-Catalyzed Synthesis of Chiral Aryl Glycines

Synthesis of Loratadine

Progress Towards the Total Syntheses of Amaryllidaceae Alkaloids Γ‐lycorane

Recent advances in the total synthesis of galantamine, a natural medicine for Alzheimer's disease

Improved synthesis of 3-(3-chloro-1,2, 5-thiadiazol-4-yl) pyridine

Rhodium-Catalyzed Hydrocarbonylation of a Homoallylamine via N–H Activation and Application for Synthesis of Yohimbane Alkaloids

3D-QSAR Studies of Galanthamine and Analogs

ChemInform Abstract: Rh‐Catalyzed [5 + 1] Cycloaddition of Allenylcyclopropanes and CO: Reaction Development and Application to the Formal Synthesis of (‐)‐Galanthamine.

Formal Synthesis of (±)-Allocolchicine Via Gold-Catalysed Direct Arylation: Implication of Aryl Iodine(III) Oxidant in Catalyst Deactivation Pathways

Synthetic studies toward galbulimima alkaloid (-)-GB 13 and (+)-GB 16 and (-)-himgaline.